Health

Minister sees industry at US$14bn by 2022 Patel bullish on medical devices. The Indian medical technology industry would grow to US$14 billion by 2022 from the present level of US$1.4 billion, riding on the back of unprecedented digital initiatives and...

Industry grew at 17.46% CAGR in a decade Over the last decade, pharmaceutical companies in India has witnessed tremendous growth and advances with a CAGR of 17.46% and market value of US$36.7 billion in 2016, says BizVibe. With pharmaceutical research...

Supratech to get DNA sequencing data technique.   Saphetor SA, the Swiss precision-medicine company dedicated to advancing personalized diagnostics, will provide its proprietary platform for analyzing next-generation DNA sequencing data to Supratech Micropath of Ahmedabad, a reference and diagnostic lab...

NAM earmarks Rs.440 crore for medical facilities. The government has approved 39 hospitals, each of 50-bed, from 45 proposals received during 2016-17, said Minister of State for AYUSH (Independent Charge), Shripad Yesso Naik in reply to a question in Lok...

Govt grant provided to the State/UT Governments A total of 25 ‘50-bedded’ hospitals with an outlay of Rs.145 crore has been approved in the year 2016-17, the Rajya Sabha was told on 18 July 2017. Under Centrally Sponsored Scheme of...

Zip Surgical Skin Closure device for Indians. ZipLine® Medical, Inc., an innovator in skin closure, gets approval to enter the US$3.5 billion medical device market in India. Zipline has received approval from the Central Drugs Standard Control Organization (CDSCO) for...

Electrolab partnership to help Simulations Plus in India. The Indian pharmaceutical market is expected to continue to enjoy robust growth as it has in the past 10 years, said a California-based executive. John DiBella, vice president for marketing and sales...

TA invests in Ideal Cures #TA Associates, a leading global growth private equity firm, has completed an investment in India’s #Ideal Cures Private Limited, which has expansion plans in the healthcare sector. Financial terms of the transaction were not disclosed...

Vyome gel for acne #Vyome Biosciences has announced on 7 Feb 2017 top-line data from its phase 1 clinical trial evaluating VB-1953, a topically administered gel designed to treat patients with moderate to severe acne. VB-1953 exhibited a promising dermal safety signal, was...

Merck grant for ECHO A Merck-ECHO project. #The Merck Foundation has provided a grant of US$7 million over five years to help improve health in India and Vietnam. The grant is for projects by the #Extension for Community Healthcare Outcomes...